This work presents an immune‐stimulating UCNP‐based PDT strategy in combination with CTLA‐4 checkpoint blockade to effectively destroy primary tumors under light exposure, inhibit distant tumors that can hardly be reached by light, and prevent tumor reoccurrence via the immune memory effect. Here, CTLA4 is linked to neoplasm.